Thu, July 26, 2018
Wed, July 25, 2018
Tue, July 24, 2018

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $392 on, Jul 25th, 2018

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $366 to $392 on, Jul 25th, 2018.

Matthew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018